MedPlus Health Services has scheduled its 20th Annual General Meeting (AGM) for Monday, August 17, 2026, to approve critical board appointments and financial resolutions. The meeting, conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), will see shareholders vote on the re-appointment of Managing Director & CEO Gangadi Madhukar Reddy for a five-year term, alongside the induction of two new independent directors. This governance update follows the company’s filing of its FY26 Annual Report, which reported a consolidated revenue of ₹68,924.66 million and a profit after tax of ₹2,196.06 million.

The AGM agenda includes ordinary business items such as the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. Dr. Cherukupalli Bhaskar Reddy, Whole Time Director, retires by rotation and seeks re-appointment. Shareholders holding shares as of the cut-off date, August 10, 2026, are eligible to participate in remote e-voting, which opens on August 14, 2026, at 09:00 AM IST and closes on August 16, 2026, at 05:00 PM IST.

Key Resolutions and Board Appointments

The special business section of the AGM focuses on strengthening the board’s composition with diverse expertise. The Nomination and Remuneration Committee recommended the appointment of Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar as Independent Directors. Both appointments require special resolutions under Regulation 17(1A) of the SEBI LODR Regulations due to their age exceeding or approaching 75 years.

Mr. Mohan Krishna Reddy brings over three decades of experience in finance and strategy, including roles at Indian Bank, Unit Trust of India, and JM Financial. Mr. Ajit Pandurang Rangnekar offers more than 50 years of leadership experience across manufacturing, services, and consulting sectors, including a B.Tech from IIT Bombay and a PGP from IIM Ahmedabad.

Re-appointment of Managing Director & CEO

Shareholders will also vote on the re-appointment of Gangadi Madhukar Reddy as Managing Director & CEO for a period of five years, commencing August 03, 2026, and ending August 02, 2031. His consolidated remuneration is capped at ₹4.00 million per annum, subject to limits prescribed under the Companies Act, 2013. In the event of inadequate profits, his remuneration will adhere to Schedule V of the Act. Mr. Reddy, who holds an MBA from Wharton School, has been instrumental in driving the company’s expansion to over 5,330 stores across 13 states and one union territory.

Auditor Ratification and Governance

The AGM will also ratify the remuneration of M/s. M P R & Associates, Cost Accountants, as Cost Auditors for FY27. The approved fee is ₹1,50,000 plus applicable taxes and out-of-pocket expenses. The Statutory Auditors for FY26 were M/s. B S R and Co., which issued an unqualified audit report. The Secretarial Audit by M/s. R & A Associates contained no qualifications.

E-Voting and Meeting Logistics

KFin Technologies Limited serves as the Registrar and Transfer Agent and e-voting service provider. Members can cast votes via remote e-voting using credentials linked to their demat accounts or physical folios. The facility for attending the AGM virtually is available on a first-come, first-served basis for up to 1,000 members, excluding large shareholders, promoters, and institutional investors. Questions from members must be submitted at least 72 hours before the AGM via the designated email IDs or the e-voting portal.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE804L01022/998fd76c-9619-414c-9115-3279df5d440e.pdf

Medplus Health Services reported a 21.8% year-on-year increase in revenue to ₹18,796 million for the quarter ended June 30, 2026 (Q1FY27). Despite the top-line growth, net profit after tax (PAT) declined by 21.7% to ₹331.7 million, impacted by margin contraction. The Board of Directors approved the unaudited standalone and consolidated financial results on July 21, 2026, along with significant capital expenditure plans totalling ₹1,550 million. Subsequently, the company submitted the audio recording of the earnings call held on July 22, 2026, with analysts and institutional investors to discuss these results.

Financial Performance

The revenue growth was primarily driven by the retail segment, which contributed ₹18,423.92 million. However, the gross margin contracted by 160 basis points year-on-year to 24.5%, attributed to a lower sales mix of private label products and lower margins realized in the franchisee business. The operating EBITDA margin fell to 3.5% from 4.7% in the prior year, while the EBITDA margin stood at 7.1% compared to 8.47% in the corresponding period of the previous year.

Segment Performance

The retail segment saw its operating EBITDA drop by 14.8% year-on-year to ₹588.1 million, with margins shrinking to 3.2%. Conversely, the diagnostics segment showed strong growth, with revenue rising 22.4% to ₹370.8 million and operating EBITDA increasing 59.5% to ₹65.9 million.

Strategic Updates

The Board approved a CAPEX plan of approximately ₹400 million for Optival Health Solutions Private Limited, a material subsidiary, to set up a Food Park including a Cold Press Oil Extraction Unit at Hyderabad. Additionally, the company approved an investment of approximately ₹1,150 million to establish a Concierge Health & Wellness Services Facility in Hyderabad, comprising capital expenditure of ₹900 million. The Board also appointed Mr. Shrenik Soni as Company Secretary and Compliance Officer effective July 21, 2026.

Regulatory Filings

The company submitted newspaper clippings of the unaudited financial results published in the Financial Express and Nava Telangana on July 22, 2026, to the BSE and NSE. Furthermore, the Board scheduled the Twentieth Annual General Meeting (AGM) for Monday, August 17, 2026, at 03:30 P.M. via Video Conferencing. Remote e-voting facilities will be available to members as on the cut-off date of August 10, 2026.